Efficacy and safety of GSK3772847 in participants with moderate-to-severe asthma with allergic fungal airway disease: A phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trial

INTRODUCTION: Current treatments for allergic fungal airway disease are not specific for asthma and are associated with limited efficacy or safety concerns. This Phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trial assessed the efficacy and safety of GSK3772847, an anti-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinseye, Chika, Crim, Courtney, Newlands, Amy, Fairman, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897512/
https://www.ncbi.nlm.nih.gov/pubmed/36735745
http://dx.doi.org/10.1371/journal.pone.0281205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897512/
https://www.ncbi.nlm.nih.gov/pubmed/36735745
http://dx.doi.org/10.1371/journal.pone.0281205

Ejemplares similares